1. An 18‐year climatology of hailstorm trends and related drivers across southeast Queensland, Australia. (January 2017) Authors: Soderholm, J. S.; McGowan, H.; Richter, H.; Walsh, K.; Weckwerth, T. M.; Coleman, M. Journal: Quarterly journal of the Royal Meteorological Society Issue: Volume 143:Number 703(2017) Page Start: 1123 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Tumour suppression by a protein hydroxylase. (July 2016) Authors: Zayer, A.; Smith, H.; Pillai, M.; Sekirnik, R.; Zak, J.; Lu, X.; Schofield, C.; Bix, M.; Ratcliffe, P.; Coleman, M. Journal: European journal of cancer Issue: Volume 61(2016)Supplement 1 Page Start: S91 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Phase 2 Study of Selinexor in Patients with Myelodysplastic Syndromes Refractory to Hypomethylating Agents: Interim Report. (April 2017) Authors: Klimek, V.M.; Coleman, M.; Alvarez, K.; Sen, F.; Pichardo, J.; Kashyap, T.; Klebanov, B. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S32 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Macro-to-nanoscale investigation of wall-plate joints in the acorn barnacle Semibalanus balanoides: correlative imaging, biological form and function, and bioinspiration. Issue 157 (7th August 2019) Authors: Mitchell, R. L.; Coleman, M.; Davies, P.; North, L.; Pope, E. C.; Pleydell-Pearce, C.; Harris, W.; Johnston, R. Journal: Journal of the Royal Society interface Issue: Volume 16:Issue 157(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PHASE 2 STUDY OF ACALABRUTINIB IN IBRUTINIB‐INTOLERANT PATIENTS WITH RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA. (12th June 2019) Authors: Rogers, K.A.; Thompson, P.A.; Allan, J.N.; Coleman, M.; Sharman, J.P.; Cheson, B.D.; Izumi, R.; Frigault, M.M.; Quah, C.; Raman, R.K.; Wang, M.H.; Kipps, T.J. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 60 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. INTERIM ANALYSIS OF PHASE IIIB MAGNIFY STUDY OF INDUCTION R2 FOLLOWED BY MAINTENANCE IN PATIENTS WITH RELAPSED/REFRACTORY INDOLENT NON‐HODGKIN LYMPHOMA. (12th June 2019) Authors: Sharman, J.; Coleman, M.; Yacoub, A.; Melear, J.; Fanning, S.; Kolibaba, K.; Lansigan, F.; Reynolds, C.; Foon, K.; Li, J.; Llorente, M.; Rummel, M.; Andorsky, D. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 115 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. PHASE 2 STUDY OF PARSACLISIB (INCB050465) FOR RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) (CITADEL‐202). (12th June 2019) Authors: Belada, D.; Fay, K.; Casasnovas, R.; Gressin, R.; Lee, H.; Mehta, A.; Munoz, J.; Verhoef, G.; Corrado, C.; DeMarini, D.; Zhao, W.; Chen, X.; Coleman, M. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 326 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. MULTI‐CENTER PHASE II STUDY OF ORAL AZACITIDINE (CC‐486) PLUS CHOP AS INITIAL TREATMENT FOR PERIPHERAL T‐CELL LYMPHOMA. (12th June 2019) Authors: Ruan, J.; Leonard, J.P.; Coleman, M.; Rutherford, S.; Van Besien, K.; Rodriguez, A.; Benderoff, L.; Mehta‐Shah, N.; Moskowitz, A.; Sokol, L.; Cerchietti, L.; Inghirami, G.; Martin, P. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 560 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. PHASE IIIB STUDY OF LENALIDOMIDE PLUS RITUXIMAB FOLLOWED BY MAINTENANCE IN RELAPSED OR REFRACTORY NHL: ANALYSIS OF MARGINAL ZONE LYMPHOMA. (June 2017) Authors: Coleman, M.; Andorsky, D.J.; Yacoub, A.; Melear, J.M.; Kolibaba, K.S.; Brooks, H.D.; Bitran, J.D.; Fanning, S.R.; Lansigan, F.; Ricker, J.L.; Foon, K.A.; Llorente, M.; Li, J.; Sharman, J.P. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 148 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Safety and efficacy of single‐agent ibrutinib in patients with relapsed/refractory (R/R) marginal zone lymphoma (MZL): A multicenter, open‐label, phase 2 study. (June 2017) Authors: Collins, G.P.; Noy, A.; de Vos, S.; Thieblemont, C.; Martin, P.; Flowers, C.; Morschhauser, F.; Ma, S.; Coleman, M.; Peles, S.; Smith, S.; Barrientos, J.; Smith, A.; Munneke, B.; Dimery, I.; Beaupre, D.; Chen, R. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 211 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗